The paradoxical association between inherited factor VII deficiency and venous thrombosis

Haemophilia

Volumn 14, Issue 3, 2008, Pages 564-570

  Marty, S ^a   Barro, C ^b   Chatelain, B ^c   Fimbel, B ^d   Tribout, B ^e   Reynaud, J ^f   Schved, J F ^a   Giansily blaizot, Muriel ^a  

^a HÔPITAL SAINT ELOI   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d UNIVERSITY HOSPITAL OF TOURS   (France)

^e AMIENS UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Antithrombotic prophylaxis; F7 mutations; Inherited factor VII deficiency; Thrombotic risk factors; Venous thrombosis

Indexed keywords

ALANINE; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 7; CONTRACEPTIVE AGENT; GLYCINE; PHOSPHOLIPID BINDING PROTEIN; PROTHROMBIN COMPLEX;

ADULT; AGED; ARTICLE; BLOOD CLOTTING FACTOR 7 DEFICIENCY; EXON; FAMILY HISTORY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE; HEMATOMA; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MITRAL VALVE PROLAPSE; NUCLEOTIDE SEQUENCE; PHENOTYPE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR; SUBSTITUTION THERAPY; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; ANTIGENS; BLOOD COAGULATION FACTORS; COAGULANTS; DNA MUTATIONAL ANALYSIS; FACTOR VII; FACTOR VII DEFICIENCY; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; RISK FACTORS; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 43149123350     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2007.01647.x     Document Type: Article

References (35)

1. Mariani G, Herrmann FH, Dolce A et al. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost 2005; 93: 481-7.
2. Peyvandi F, Mannucci PM, Billio A, Zeinali S, Perkins SJ, Perry DJ. Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency. Haemophilia 1997; 3: 242-6.
3. Goodnough LT, Saito H, Ratnoff OD. Thrombosis or myocardial infarction in congenital clotting factor abnormalities. Medicine 1983; 62: 248-55.
4. Escoffre M, Zini JM, Schliamser L et al. Severe arterial thrombosis in a congenitally factor VII deficient patient. Br J Haematol 1995; 91: 739-41.
5. Gershwin ME, Gude JK. Deep vein thrombosis and pulmonary embolism in congenital factor VII deficiency. N Engl J Med 1973; 288: 141-2.
6. Sabharwal AK, Kuppuswamy NM, Foster DC et al. Factor VII deficiency (FVIIRichmond, R304Q mutant) associated with thrombosis. Circulation 1992; 88: 679.
7. Giansily-Blaizot M, Verdier R, Biron-Andréani C et al. Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: Can biological tests predict the bleeding risk? Haematologica 2004; 89: 704-9.
8. Giansily-Blaizot M, Aguilar-Martinez P, Biron-Andreani C, Jeanjean P, Igual H, Schved JF. Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency. Eur J Hum Genet 2001; 9: 105-12.
9. Mariani G, Herrmann FH, Schulman S et al. Thrombosis in inherited factor VII deficiency. J Thromb Haemost 2003; 1: 2153-8.
10. Lietz K, Kuehling SE, Parkhurst JB. Hemorrhagic stroke in a child with protein S and factor VII deficiencies. Pediatr Neurol 2005; 32: 208-10.
11. Kang HS, Kim DG, Yoon BW. Superior sagittal sinus thrombosis with homocystinuria and deficiency of antithrombin III and factor VII: Case report. Acta Neurochir (Wien) 1998; 140: 196-8.
12. Meissner MH, Chandler WL, Elliott JS. Venous thromboembolism in trauma: a local manifestation of systemic hypercoagulability? J Trauma 2003; 54: 224-31.
13. Trojet S, Loukil I, El Afrit MA et al. Bilateral retinal vascular occlusion during antiphospholipid antibody syndrome: A case report. J Fr Ophtalmol 2005; 28: 503-7.
14. Harmanci O, Ersoy O, Gurgey A et al. The etiologic distribution of thrombophilic factors in chronic portal vein thrombosis. J Clin Gastroenterol 2007; 41: 521-7.
15. Wilde JT. Evidence for the use of activated prothrombine complex concentrates (aPCCs) in the treatment of patients with haemophilia and inhibitors. Pathophysiol Haemost Thromb 2002; 32(Suppl. 1): 9-12.
16. Aledort LM. Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus FVIII inhibitor bypass activity. J Thromb Haemost 2004; 2: 1700-8.
17. Ben Dridi MF, Karoui S, Kastally R, Gharbi HA, Zaimi I, Ben Osman R. Homocystinuria. A type with vascular thrombosis and factor VII deficiency. Arch Fr Pediatr 1986; 43: 41-4.
18. Kamphuisen PW, Eikenboom JC, Bertina RM. Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 2001; 21: 731-8.
19. Kyrle PA, Minar E, Hirschl M et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000; 343: 457-62.
20. Asherson RA, Khanashta MA, Hughes GR. Antiphospholipid antibodies, lupus-like disease and the 'primary'antiphospholipid syndrome. Clin Rheumatol 1989; 8: 115-7.
21. Castoldi E, Govers-Riemslag JW, Pinotti M et al. Coinheritance of factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726 + 5G>A (FVII Lazio) mutation. Blood 2003; 102: 4014-20.
22. Nichols WC, Amano K, Cacheris PM et al. Moderation of hemophilia A phenotype by the factor V R506Q mutation. Blood 1996; 88: 1183-7.
23. Tizzano EF, Soria JM, Coll I et al. The prothrombin 20210A allele influences clinical manifestations of hemophilia A in patients with intron 22 inversion and without inhibitors. Haematologica 2002; 87: 279-85.
24. Strey RF, Siegemund A, Siegemund T et al. Influence of factor V HR2 on thrombin generation and clinical manifestation in rare bleeding disorders. Pathophysiol Haemost Thromb 2005; 34: 279-83.
25. Giansily-Blaizot M, Aguilar-Martinez P, Briquel ME et al. Two novel cases of cerebral haemorrhages at the neonatal period associated with inherited factor VII deficiency, one of them revealing a new nonsense mutation (Ser52Stop). Blood Coagul Fibrinolysis 2003; 14: 217-20.
26. Hunault M, Arbini AA, Carew JA, Peyvandi F, Bauer KA. Characterization of two naturally occurring mutations in the second epidermal growth factor-like domain of factor VII. Blood 1999; 93: 1237-44.
27. Wulff K, Herrmann FH. Twenty two novel mutations of the factor VII gene in factor VII deficiency. Hum Mutat 2000; 15: 489-96.
28. Pinotti M, Toso R, Redaelli R, Berrettini M, Marchetti G, Bernardi F. Molecular mechanisms of FVII deficiency: Expression of mutations clustered in the IVS7 donor splice site of factor VII gene. Blood 1998; 92: 1646-51.
29. Pinotti M, Toso R, Girelli D et al. Modulation of factor VII levels by intron 7 polymorphisms: Population and in vitro studies. Blood 2000; 95: 3423-8.
30. Etro D, Pinotti M, Wulff K et al. The Gly331Ser mutation in factor VII in Europe and the Middle East. Haematologica 2003; 88: 1434-6.
31. O'Brien DP, Gale KM, Anderson JS et al. Purification and characterization of factor VII 304-Gln - a variant molecule with reduced activity isolated from a clinically unaffected male. Blood 1991; 78: 132-40.
32. Toso R, Pinotti M, High KA, Pollak ES, Bernardi F. A frequent human coagulation factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates. Biochem J 2002; 363: 411-6.
33. Fromovich-Amit Y, Zivelin A, Rosenberg N, Tamary H, Landau M, Seligsohn U. Characterization of mutations causing factor VII deficiency in 61 unrelated Israeli patients. J Thromb Haemost 2004; 2: 1774-81.
34. Mariani G, Konkle BA, Ingerslev J. Congenital factor VII deficiency: therapy with recombinant activated factor VII - a critical appraisal. Haemophilia 2006; 12: 19-27.
35. Girolami A, Ruzzon E, Tezza F, Scandellari R, Vettore S, Girolami B. Arterial and venous thrombosis in rare congenital bleeding disorders: A critical review. Haemophilia 2006; 12: 345-51.